Companies
Fermentalg
- Country
- France
- Ticker
- FALG.PA
ccus
eu
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| aquaculture-seafood | ✓ | ✓ | — | ✓ |
| food-alt-protein | ✓ | ✓ | — | ✓ |
| marine-biotech | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpaepamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Revenue | €13.4 million for 2025 | actusnews.com |
| Capacity | ~10,000 m³ fermentation capacity through partnership with Huvepharma | fermentalg.com |
| Certification | FSSC 22000, GMP, ISO 14001, My Green Lab, Silver EcoVadis | fermentalg.com |
| Regulatory approval | FDA approval for blue colorant (May 2025); EFSA favorable opinion for blue colorant (March 2026) | lesechos-comfi.lesechos.fr · actusnews.com |
| Production site | Pilot facilities in Libourne, France; large-scale production via European partners (e.g., Huvepharma) | fermentalg.com |
Independent sources: actusnews.com · lesechos-comfi.lesechos.fr
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| CO2 valorization via microalgae | marine-biotech | Medium | → |
| Microalgal omega-3 (EPA/DHA algal oils) | aquaculture-seafood | Low | → |
| Precision fermentation of fats & oils | food-alt-protein | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.